Latest Asx News

LDR Assets Pty Ltd, part of the Lederer Family Office, has initiated an off-market takeover offer for all stapled securities in the Elanor Commercial Property Fund at a 5.3% premium to recent prices. The bid signals a potential overhaul of ECF’s management and governance.

Redcastle Resources Limited has resumed trading on the ASX following key announcements about a joint venture farm-out, a strategic placement, and a major gold project acquisition.

Redcastle Resources has partnered with BML Ventures to fast-track gold production at key deposits while massively expanding its Eastern Goldfields footprint through a strategic tenement acquisition.

Genetic Technologies Limited reports a 36% increase in half-year losses amid voluntary administration, followed by a recapitalisation and sale of core assets. The company pivots towards new financial services acquisitions under fresh leadership.

HomeCo Daily Needs REIT has announced a quarterly distribution of 2.125 cents per unit for Q2 2025, alongside confirmation of its Attribution Managed Investment Trust status for the fiscal year.

Magnetite Mines has launched a $2.65 million renounceable rights issue with increased underwriting support, following promising rare earth mineralisation findings at its Ironback Hill Project.

Frontier Digital Ventures has uncovered apparent misappropriation of approximately USD 430,000 within its Colombian business, Fincaraiz, prompting an ongoing investigation and operational safeguards.

Vicinity Centres confirms its distribution reinvestment plan will apply to the FY25 final distribution, offering investors a 1% discount on new securities issued under the plan.

Marquee Resources has successfully closed an oversubscribed $2.51 million placement, underscoring strong investor confidence as it prepares for the next phase of drilling at its Mt Clement Antimony Project.

Invion Limited secures a pivotal FDA Orphan Drug Designation for its lead candidate INV043, targeting anal cancer with promising preclinical results and a fast-tracked development path.

Invion Limited has disclosed that the US FDA granted Orphan Drug Designation for its lead cancer drug candidate INV043, explaining recent unusual trading activity in its shares. The company confirmed it was unaware of the FDA decision prior to its public release and has now complied with continuous disclosure rules.

FirstWave Cloud Technology is launching its first AI-powered compliance management feature for Open-AudIT, aiming to convert a large base of free users into paying customers through a subscription model integrated with AWS.